The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 19, 2025
Filed:
Nov. 20, 2019
Applicant:
Bavarian Nordic A/s, Hellerup, DK;
Inventors:
Henning Lauterbach, Eching, DE;
Maria Hinterberger, Sauerlach, DE;
José Medina Echeverz, Munich, DE;
Assignee:
Bavarian Nordic A/S, Hellerup, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/21 (2006.01); A61K 9/00 (2006.01); A61K 35/76 (2015.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001138 (2018.08); A61K 9/0019 (2013.01); A61K 35/76 (2013.01); A61K 39/0011 (2013.01); A61K 39/001102 (2018.08); A61K 39/001106 (2018.08); A61K 39/001149 (2018.08); A61K 39/00115 (2018.08); A61K 39/001152 (2018.08); A61K 39/001156 (2018.08); A61K 39/00117 (2018.08); A61K 39/001182 (2018.08); A61K 39/00119 (2018.08); A61K 39/001193 (2018.08); A61K 39/001194 (2018.08); A61P 35/00 (2018.01); A61K 2039/5256 (2013.01);
Abstract
The invention relates to a composition and related methods for reducing tumor volume and/or increasing the survival of a cancer patient. The composition comprises a recombinant MVA encoding a Tumor Associated Antigen ('TAA') as well as 4-1BBL and/or CD40L and can be administered to a subject in any suitable manner, including by intravenous and/or intratumoral administration.